MedTrace Logo

The Addition of Sufentanil Interscalene Block in Shoulder Surgery

NCT01025102 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2013-04-02

No results posted yet for this study

Summary

The purpose of this study is to compare the effects and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.

Conditions

  • Postoperative Pain
  • Shoulder Surgery

Interventions

DRUG

Naropin 0.1% cum sufentanil

20ml of Naropin 0.1% cum sufentanil 1mikrog per ml

Sponsors & Collaborators

  • Bent Gymoese Jorgensen

    lead OTHER

Principal Investigators

  • Bent G Jørgensen, MD · Anesthetic Clinic, Frederiksberg University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01025102 on ClinicalTrials.gov